PF-00299804 (neratinib)

neratinib · Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-00299804 (neratinib), covering 2015-11-20 to 2015-11-20. Get the full timeline:

Most recent: Clinical Trial Update: PF-00299804 Monotherapy in Patients With HER-2 Positive Advance Gastric Cancer [Phase 2]